HCMC Healthier Choices Management Corp.
Tobacco Products · OTC · SEC CIK 844856 · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-18.8%
TTM net income YoY35.7%
TTM EPS YoY—
Revenue 3-yr CAGR-96.6%
Net income 3-yr CAGR—
Margins
Gross margin-13,234.5%
Operating margin-1,697,351.3%
Net margin-2,373,421.8%
FCF margin-739,084.6%
EBITDA margin-1,684,323.4%
Returns
ROE-457.6%
ROA-71.7%
ROIC (approx.)-344.1%
Asset turnover0.00x
Leverage & solvency
Liabilities / assets120.3%
Debt / equity—
Current ratio0.73x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.31x
Accruals ratio-49.6%
Payout ratio—
Capex / revenue9,418.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2,979 | $501 | $617 | $29.27M | $13.32M |
| Cost of revenue | $30,920 | $66,806 | $787 | — | — |
| Gross profit | -$27,941 | -$66,305 | -$170 | $10.22M | $5.29M |
| SG&A expense | — | $1.00M | $32.22M | $18.88M | $10.03M |
| Operating income | -$7.03M | -$8.50M | -$7.45M | -$8.65M | -$4.74M |
| Interest expense | — | — | — | — | $65,281 |
| Income tax | — | — | — | $0 | $0 |
| Net income | -$7.02M | -$11.89M | -$18.48M | -$7.22M | -$4.04M |
| EBITDA | -$6.99M | -$8.44M | -$5.96M | -$7.59M | -$4.24M |
| EPS (basic) | — | — | 0.00 | 0.00 | 0.00 |
| EPS (diluted) | — | — | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 481.27B | 479.70B | 429.92B | 339.74B | 307.91B |
| Banking | |||||
| Net interest income | $34,741 | $126,000 | $411,677 | $202,653 | — |
| Balance sheet | |||||
| Cash & equivalents | $1.14M | $1.19M | $3.66M | $24.69M | $26.50M |
| Short-term investments | — | — | — | $9,771 | $23,143 |
| Receivables | $199 | — | $128,171 | $55,815 | $28,481 |
| Inventory | $36,148 | $40,460 | $66,671 | $3.82M | $1.52M |
| Current assets | $1.34M | $1.95M | $11.73M | $30.31M | $28.77M |
| PP&E, net | $7,789 | $80,541 | $58,613 | $3.11M | $176,988 |
| Goodwill | — | — | — | $5.75M | $916,000 |
| Intangibles | $119,026 | $158,151 | $198,163 | $5.01M | $947,593 |
| Total assets | $1.47M | $2.22M | $30.97M | $55.26M | $34.44M |
| Current liabilities | $1.59M | $2.67M | $12.23M | $9.91M | $2.52M |
| Short-term debt | — | — | $1.16M | $536,542 | $2,604 |
| Long-term debt | — | — | $2.40M | $2.38M | $815 |
| Total debt | — | — | $3.56M | $2.91M | $3,419 |
| Total liabilities | $1.59M | $2.67M | $23.10M | $20.33M | $5.21M |
| Shareholders' equity | -$1.23M | -$1.56M | $6.76M | $20.21M | $29.23M |
| Net debt | — | — | -$98,766 | -$21.78M | -$26.49M |
| Shares outstanding | 525.16B | 481.27B | 478.27B | 339.74B | 339.74B |
| Cash flow statement | |||||
| Operating cash flow | -$3.88M | -$3.66M | -$4.74M | -$3.87M | -$3.53M |
| Capital expenditure | — | $47,185 | $184,349 | $480,925 | $56,418 |
| Free cash flow | — | -$3.70M | -$4.92M | -$4.35M | -$3.58M |
| Investing cash flow | — | -$4.92M | -$768,555 | -$10.73M | -$87,322 |
| Financing cash flow | $3.37M | $4.69M | -$13.55M | $12.79M | $27.19M |
| Depreciation & amortization | $47,817 | $65,270 | $1.49M | $1.06M | $497,408 |
| Stock-based compensation | $3.40M | $4.62M | $3.43M | $72,222 | $34,375 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.